Back HIV/AIDS HIV/AIDS Topics HIV Prevention

AIDS 2016: Study Looks at Use of HIV PrEP During Pregnancy and Breastfeeding

Truvada for pre-exposure prophylaxis (PrEP) when it was offered as an additional tool for preventing HIV infection during the pre-conception period, pregnancy, and breastfeeding, according to study findings presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban and published in the July 19 online edition of the American Journal of Obstetrics and Gynecology.

alt

Read more:

Truvada PrEP for HIV Prevention Approved in European Union

The European Commission, which has authority over new drug in the European Union, has approved Truvada (tenofovir/emtricitabine) for HIV pre-exposure prophylaxis or PrEP, Gilead Sciences announced this week. While this marketing authorization allows Truvada for PrEP to be sold throughout the EU, regulatory authorities in each country have the final say over whether to approve it and national health systems will decide whether to offer PrEP widely and pay for it.

alt

Read more:

AIDS 2016: Vaginal Bacteria May Increase HIV Susceptibility and Reduce PrEP Effectiveness

Overgrowth of a certain species of vaginal bacteria was associated with a 13-fold higher likelihood of becoming infected with HIV, while another species was found to lower tenofovir levels and may contribute to reduced efficacy of pre-exposure prophylaxis (PrEP) delivered in a vaginal gel, according to a set of presentations at the 21st International AIDS Conference (AIDS 2016) last month in Durban.

alt

Read more:

Most Contraceptives Not Linked to HIV Infection, but Depo-Provera May Raise Risk

Birth control pills and some types of injectable and implanted contraceptives were not associated with an increased risk of HIV acquisition in an updated meta-analysis that included several recent studies, researchers reported in the August 5 online edition of AIDS. However, evidence continues to suggest that use of depot medroxyprogesterone acetate (DMPA or Depo-Provera) raises the likelihood of HIV infection. The World Health Organization (WHO) plans to meet soon to assess whether guidance needs to change in the light of the new findings.

alt

Read more:

AIDS 2016: No New HIV Infections Seen in San Francisco's Strut PrEP Program

A community-based sexual health clinic in San Francisco has offered nurse-led pre-exposure prophylaxis (PrEP) services to more than 1200 clients and seen no HIV infections to date, according to a presentation last month at the 21st International AIDS Conference (AIDS 2016) in Durban.

alt

Read more: